The anti-proliferative activity of the title compounds was reinforced by molecular docking with urokinase plasminogen activator (uPA), a serine protease whose overexpression is closely associated with tumor cell migration, invasion, proliferation, progression, and metastasis (Reuning et al., 1998). The gene discussed is PLAU; the disease is neoplasm.